Elutia Inc
ELUT0.586USD
+0.044+8.03%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
24.95MMarket Cap
LossP/E TTM
More Details of Elutia Inc Company
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. It is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.
Elutia Inc Info
Ticker SymbolELUT
Company nameElutia Inc
IPO dateOct 08, 2020
CEOMills (C. Randal)
Number of employees51
Security typeOrdinary Share
Fiscal year-endOct 08
Address12510 Prosperity Drive
CitySILVER SPRING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code20904
Phone12402471143
Websitehttps://elutia.com/
Ticker SymbolELUT
IPO dateOct 08, 2020
CEOMills (C. Randal)
Company Executives of Elutia Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Matthew B. (Matt) Ferguson
Mr. Matthew B. (Matt) Ferguson
Chief Financial Officer
Chief Financial Officer
379.07K
+2.71%
Dr. Michelle LeRoux Williams, Ph.D.
Dr. Michelle LeRoux Williams, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
93.39K
+10.08%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
90.81K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Director
Director
68.75K
+10.00%
Mr. David Colpman
Mr. David Colpman
Independent Director
Independent Director
18.60K
+500.32%
Ms. Brigid A. Makes
Ms. Brigid A. Makes
Independent Director
Independent Director
2.00K
--
Dr. C. Randal (Randal) Mills, Ph.D.
Dr. C. Randal (Randal) Mills, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Matthew B. (Matt) Ferguson
Mr. Matthew B. (Matt) Ferguson
Chief Financial Officer
Chief Financial Officer
379.07K
+2.71%
Dr. Michelle LeRoux Williams, Ph.D.
Dr. Michelle LeRoux Williams, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
93.39K
+10.08%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
90.81K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Director
Director
68.75K
+10.00%
Mr. David Colpman
Mr. David Colpman
Independent Director
Independent Director
18.60K
+500.32%
Ms. Brigid A. Makes
Ms. Brigid A. Makes
Independent Director
Independent Director
2.00K
--
Revenue Breakdown
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Device protection
3.52M
0.00%
Women's health
2.01M
0.00%
Cardiovascular
736.00K
0.00%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Device protection
3.52M
0.00%
Women's health
2.01M
0.00%
Cardiovascular
736.00K
0.00%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Highcape Partners, L.P.
12.65%
Nantahala Capital Management, LLC
7.89%
SilverArc Capital Management, LLC
7.07%
Alyeska Investment Group, L.P.
6.55%
AIGH Capital Management, LLC.
5.01%
Other
60.83%
Shareholders
Shareholders
Proportion
Highcape Partners, L.P.
12.65%
Nantahala Capital Management, LLC
7.89%
SilverArc Capital Management, LLC
7.07%
Alyeska Investment Group, L.P.
6.55%
AIGH Capital Management, LLC.
5.01%
Other
60.83%
Shareholder Types
Shareholders
Proportion
Hedge Fund
25.34%
Private Equity
17.66%
Investment Advisor
10.45%
Individual Investor
3.94%
Investment Advisor/Hedge Fund
3.65%
Research Firm
0.31%
Other
38.64%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
54
27.56M
66.51%
--
2025Q3
56
27.56M
70.55%
+656.18K
2025Q2
56
26.90M
72.35%
+168.09K
2025Q1
57
26.74M
61.68%
+4.19M
2024Q4
57
22.31M
69.12%
+1.01M
2024Q3
51
21.30M
59.47%
+5.32M
2024Q2
47
15.98M
79.08%
+3.28M
2024Q1
44
12.69M
88.87%
-5.05M
2023Q4
42
13.41M
85.74%
-1.13M
2023Q3
44
14.54M
55.43%
+5.88M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Highcape Partners, L.P.
9.52M
25%
+420.00K
+4.62%
Feb 03, 2025
Nantahala Capital Management, LLC
3.18M
8.36%
--
--
Jun 30, 2025
SilverArc Capital Management, LLC
2.76M
7.25%
+91.63K
+3.43%
Jun 30, 2025
Alyeska Investment Group, L.P.
2.64M
6.94%
--
--
Jun 30, 2025
AIGH Capital Management, LLC.
2.23M
5.86%
+74.89K
+3.47%
Jun 30, 2025
The Vanguard Group, Inc.
1.18M
3.1%
+191.90K
+19.41%
Jun 30, 2025
Worth Venture Partners, LLC
1.22M
3.2%
-5.28K
-0.43%
Jun 30, 2025
Perkins Capital Management, Inc.
1.15M
3.03%
+17.60K
+1.55%
Jun 30, 2025
Knollwood Investment Advisory, LLC
1.03M
2.72%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Elutia Inc?
The top five shareholders of Elutia Inc are:
Highcape Partners, L.P. holds 9.52M shares, accounting for 25.00% of the total shares.
Nantahala Capital Management, LLC holds 3.18M shares, accounting for 8.36% of the total shares.
SilverArc Capital Management, LLC holds 2.76M shares, accounting for 7.25% of the total shares.
Alyeska Investment Group, L.P. holds 2.64M shares, accounting for 6.94% of the total shares.
AIGH Capital Management, LLC. holds 2.23M shares, accounting for 5.86% of the total shares.
Highcape Partners, L.P. holds 9.52M shares, accounting for 25.00% of the total shares.
Nantahala Capital Management, LLC holds 3.18M shares, accounting for 8.36% of the total shares.
SilverArc Capital Management, LLC holds 2.76M shares, accounting for 7.25% of the total shares.
Alyeska Investment Group, L.P. holds 2.64M shares, accounting for 6.94% of the total shares.
AIGH Capital Management, LLC. holds 2.23M shares, accounting for 5.86% of the total shares.
What are the top three shareholder types of Elutia Inc?
The top three shareholder types of Elutia Inc are:
Highcape Partners, L.P.
Nantahala Capital Management, LLC
SilverArc Capital Management, LLC
Highcape Partners, L.P.
Nantahala Capital Management, LLC
SilverArc Capital Management, LLC
How many institutions hold shares of Elutia Inc (ELUT)?
As of 2025Q4, 54 institutions hold shares of Elutia Inc, with a combined market value of approximately 27.56M, accounting for 66.51% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -4.04%.
What is the biggest source of revenue for Elutia Inc?
In FY2025Q2, the Device protection business generated the highest revenue for Elutia Inc, amounting to 3.52M and accounting for --% of total revenue.
